Scarring impedes axon regrowth across the lesion site and is one major extrinsic constraint to effective regeneration in the adult mammalian central nervous system. In the present study we determined whether specific biochemical or immunochemical modulation of one major component of the scar, the basal membrane (BM), would provide a means to stimulate axon regeneration in the mechanically transected postcommissural fornix of the adult rat. Basal membrane developed within the first 2 weeks after transection in spatiotemporal coincidence with the abrupt growth arrest of spontaneously regrowing axons. Local injection of anticollagen IV antibodies or α, αЈ-dipyridyl, an inhibitor of collagen triple helix formation and synthesis, significantly reduced lesioninduced BM deposition. This treatment allowed massive axon elongation across the lesion site. Anterograde tracing provided unequivocal evidence that regenerating axons follow their original pathway, reinnervate the appropriate target, the mammillary body, and become remyelinated with compact myelin. Presynaptic electrophysiological recordings of regenerated fibre tracts showed recovery to nearly normal conduction properties. Our results indicate that lesion-induced BM is an impediment for successful axonal regeneration and its reduction is a prerequisite and sufficient condition for regrowing axons to cross the lesion site.
Introduction
Injury to adult mammalian central nervous system (CNS) initiates a cascade of non-neuronal pathophysiological events leading to the activation of glial cells and a profound remodelling of the extracellular matrix (for reviews see Maxwell et al., 1990; Schwab & Bartholdi, 1996) . These changes in the immediate environment of injured neurons play particularly important roles in the failure of axonal regeneration in the adult CNS. Three major features of the lesion-induced environment seem to be relevant in prevention of axonal regrowth: (i) the lack of appropriate levels of neurotrophic factors required for the maintenance of regrowing axons; (ii) the presence of specific negative signals that repulse or inhibit neurite growth; and (iii) the formation of a dense scar acting as a physical or chemical barrier to regenerating growth cones (for reviews see Wells & Bernstein, 1985; Carbonetto, 1991; Bähr & Bonhoeffer, 1994; Brecknell & Fawcett, 1996; Schwab & Bartholdi, 1996) . At present there is no unequivocal evidence that any of these features predominates in the failure of axonal regeneration.
In this study we focus on the potential contribution of the lesion scar as an inhibiting factor in axonal regeneration. Regardless of the type of traumatic lesion CNS reacts to isolate the area of injury or necrotic zones from intact areas by the formation of a scar. The histology of the lesion scar is dominated by the wellknown activation of astrocytes and the deposition of a basal membrane (BM) in the centre of the wound (Berry et al., 1983; Lindsay, 1986; Reier & Houle, 1988) . At maturity the lesion scar consists of tightly packed reactive astrocytes and their hyperfilamentous processes lined by a BM, which is formed by interaction of astrocytes and fibroblasts or endothelial cells (Berry et al., 1983; Bernstein et al., 1985; Bischoff, 1995; Brown & Timpl, 1995) . The BM represents a well-defined extracellular matrix (ECM) constituent with Coll IV and laminin (LN) as ubiquitous components (Timpl & Dziadek, 1986; Timpl & Brown, 1996) .
In almost all instances where regeneration failure has been described regrowing axons are either thwarted at the scar boundary or emit short sprouts into the scar tissue, where they end locally and persist for a long period (Frisén et al., 1993 (Frisén et al., , 1995 Li & Raisman, 1995) . Conversely, in rare reports of successful regeneration axons have bypassed the lesion scar to grow along connective tissue, blood vessels or bridges of surviving tissue (Clemente, 1955; Guth et al., 1983; Krüger et al., 1986; Schnell & Schwab, 1993) . Growth arrest or misrouting at the lesion border suggest that the scarring at the lesion site impedes axon regeneration. Several in-vitro and in-vivo studies of axon-astrocyte interactions favour the hypothesis that some aspect of the BM rather than the dense astrocytic network is the primary impediment to effective axonal regeneration (Fawcett et al., 1989; David et al., 1990; McKeon et al., 1991; Stichel & Müller, 1994; Berry et al., 1996) . If, however, the lesion-induced BM deposition acts as a barrier for regrowing axons, it should be possible to demonstrate that lesioned CNS axons are capable of sustained growth across the lesion site in the absence of BM.
To test the above hypothesis, we examined and correlated the spatiotemporal patterns of BM deposition and axonal regrowth after mechanical transection of a CNS fibre tract, the postcommissural fornix of the Wistar rat (Allen & Hopkins, 1989) . In addition, we developed a new experimental strategy to reduce the lesioninduced formation of BM. We injected either anti-Coll IV antibodies or a competitive inhibitor of prolyl-4-hydroxylase, the iron chelator α, αЈ dipyridyl (DPY) (Kivirikko et al., 1989) , directly into the transection site and followed the pattern of axon growth in these animals. Our data provide evidence that the BM of the lesion scar constitutes a barrier to regenerating fornix fibres and underscore the general importance of BM deposition in regeneration failure of adult mammalian CNS. A short account of this study has appeared in an abstract form (Stichel et al., 1998) .
Materials and methods

Animals
Adult Wistar rats (180-210 g) of either sex were experimental subjects. Animals were housed with free access to food and water. Institutional guidelines for animal safety and comfort were adhered to. Table 1 lists the types of treatment, the analysing methods and the number of animals used in this study.
Surgical procedures
All of the surgical interventions and pre/postsurgical animal care were provided in compliance with the German Animal Protection law.
Lesion surgery
Animals deeply anaesthetized with an intraperitoneal injection of either chloral hydrate (400 mg/kg; Sigma, Deisenhofen, germany) or a mixture of ketamine (100 mg/kg; Upjohn GmbH, Heppenheim, Germany) and rompun (5 mg/kg; Bayer, Leverkusen, Germany) were secured in a stereotaxic frame. The left postcommissural fornix of 126 rats were transected once at a distance of about 1 mm proximal to the target using a Scouten wire knife as described previously (Stichel et al., 1995b) (Fig. 1) . Briefly, a tungsten wire knife was lowered stereotactically into the brain lateral to the left fornix. The wire was extended for 3 mm in a semicircle ventral to the tract. Then the knife with the extended wire was withdrawn for 2.5 mm to cut the fornix. Finally, the wire was retracted and the knife was removed. The size of the lesioned area was µ 7.5 mm 2 and completely surrounded and Treatment  Analysis  2d  4d  6d  7d  12d  14d  21d  28d  42d  46-63d   Transection only  IHC  2  2  2  3  2  4  Tracing/LM  5  Electrophysiology  16  Anti-Coll IV  IHC  2  4  1  3  Tracing/LM, EM  3  Electrophysiology  4  D P Y  I H C  5  4  5  6  9  2  1  7  P B S  I H C  2  4  3  2  4  5  Tracing/LM  3  Anti-hm  IHC  4  4  DPY ϩ 2nd lesion  IHC  3  3  Sham injection  IHC  3 Coll, collagen; DPY, dipyridyl; EM, electron microscopy; hm, human; IHC, immunohistochemistry; LM, light microscopy.
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Completeness of transection was verified by serial reconstruction of the lesion site for each animal. Tracts were classified as regenerating if (i) macrophages filled a lesion site that extended through the tract, and (ii) regrowing axons formed a loop that was caused by the transection-induced dislocation of the fornix stumps and the attempt of the fibres to follow their previous route and/or crossed the lesion site as a perturbed array. Animals with incomplete lesions neither exhibited a perturbed array or a loop nor a continuous line of macrophages extending through the tract.
In order to transect the postcommissural fornix twice, another group of animals (n ϭ 6, see Table 1 ) received an additional lesion of the fimbria fornix.
Injections
Immediately after transection, animals (see Table 1 ) received a topical injection (1.6 µL) of either polyclonal antibodies against collagen IV (anti-Coll IV; Innovative Diagnostic System, Hamburg, Germany; 50-100 µg/mL, n ϭ 17) concentrated by centrifugation (Microcon; Amicon, Beverly, MA, USA) or the iron chelator DPY (Sigma; 1.6-16 nmol, n ϭ 45), both diluted in phosphate-buffered saline (PBS). Substances were slowly pressure injected (injection time 15 min) directly into the lesion site via a pulled-glass micropipette coupled to a microsyringe (Fig. 1) . The micropipette tip remained in place for 5 min before withdrawal. Control animals were transected and either (i) sham injected (n ϭ 3) or received equal amounts of (ii) PBS (n ϭ 23) or (iii) monoclonal antibodies against human IgG (anti-hm; Boehringer Mannheim, Germany; 50-100 µg/mL, n ϭ 8). (iv) Specimen with a second postcommissural fornix lesion at the fimbria fornix level received a DPY injection into the distal transection site only.
Animals with anti-Coll IV injections were either subjected to immunohistochemical analysis after different survival periods or to anterograde tracing and electrophysiological analysis (Table 1) . Animals with DPY injections and control animals were immunohistochemically analysed (Table 1) .
Anterograde tracing
For anterograde tracing of the postcommissural fornix 100 nL of a 2% (w/v) solution of wheat germ agglutinin-conjugated horseradish peroxidase (WGA-HRP; Sigma) were injected through pulled-glass micropipettes into both, the caudal and dorsal poles of the left (ipsilateral) subicular complex using a nanolitre pump (pump rate 10 nL/min). The total injection time was 10 min followed by another 5 min before withdrawal of the pipette.
Staining procedures
Antibodies
Rabbit polyclonal antibody against Coll IV (anti-Coll IV; diluted 1 : 3; Innovative Diagnostic System) and rabbit polyclonal antibody against LN (anti-LN; diluted 1 : 5; Innovative Diagnostic Systems) served as markers for BMs. Mouse monoclonal antibody against phosphorylated neurofilaments (anti-NF; Affinity, Nottingham, UK; diluted 1 : 2000) was used to visualize axons, while polyclonal antibody against myelin basic protein (anti-MBP; Innovative Diagnostic Systems; diluted 1 : 2) revealed the state of axonal myelination. Mouse monoclonal antibody against ED1 (anti-ED1; Camon, Wiesbaden, Germany; 1 : 2000) was applied to identify activated microglial cells and macrophages.
Immunohistochemistry
Following survival times of 2 days to 6 weeks (see Table 1 ), the brains were removed, frozen in isopentan (-50/-60°°C) and cut into serial sagittal 10 µm thick sections. Sections were fixed with acetone (10 min, -20°°C), preincubated in 3% H 2 O 2 (v/v) in methanol to block endogenous peroxidase (10 min, RT), followed by PBS containing 3% (v/v) normal horse or normal goat serum to reduce unspecific staining (10 min, RT) and then incubated alternately with one of the primary antibodies. All immunocytochemical labelling was performed by: (i) incubating mounted sections for 24 h at 4°°C in primary antibody solution in PBS; (ii) incubation for 45 min with biotinylated goat antirabbit IgG (for polyclonal antibodies, Vector Laboratories, Burlingame, CA, USA) or biotinylated horse antimouse (for monoclonal antibodies, Vector Laboratories) diluted 1 : 100 in PBS; (iii) incubation for 1 h with avidin-biotinylated peroxidase complex (ABC; Vector Standard kit, Vector Laboratories) diluted 1 : 200 in 0.1 M phosphate buffer (PB); (iv) treatment for 8-12 min with 0.05% solution of 3,3Ј-diaminobenzidine and 0.01% H 2 O 2 in PB; and (v) silver intensification as described (Stichel et al., 1990) .
For evaluation of remyelination animals (3 weeks, n ϭ 1; 6 weeks, n ϭ 1) were transcardially perfused with 4% paraformaldehyde. Brains were removed, dehydrated through a graded series of alcohols and infiltrated with paraffin. Serial 3-µm thick sagittal sections were cut, deparaffinized and incubated as described above with anti-MBP or anti-NF. Specificity of staining was confirmed by omission of the primary antibody.
Double-label immunofluorescence
To define the spatial relationship of regrowing axons and the BM deposits, double labelling for NFs and Coll IV was performed. Acetone-fixed cryostat sections were simultaneously incubated with primary antibodies (anti-NF, anti-Coll IV) overnight at 4°°C, which were visualized with CY3-conjugated antirabbit IgG (1 : 1000; Dianova, Hamburg, Germany) or biotinylated horse antimouse (1 : 100; Vector Laboratories) followed by avidin-FITC (1 : 500; Vector Laboratories). Sections were coverslipped with Vectashield (Vector Laboratories).
Tracer histology
Rats with HRP-WGA injections into the subicular complex were transcardially perfused 3 days after tracing with 4% paraformaldehyde/ 2% glutaraldehyde in PB. Serial 50 µm-thick sections were cut in the sagittal plane using a vibratome and reacted for WGA-HRP using tetramethylbenzidine as substrate (Olucha et al., 1985) .
Data analysis
All evaluations were made blind on number-coded section series. Peroxidase-labelled sections were photographed using an Olympus BH2 microscope with brightfield illumination and Nomarski optics.
Fluorescent sections were analysed by confocal laser scanning microscopy (MRC 1024, BioRad, Munich, Germany) equipped with an argon-krypton laser. Optical sections of 0.5-0.8 µm were collected from two channels with the appropriate excitation wavelengths (488 nm and 568 nm) and merged to produce a single image. In the superimposed images colocalization of the green and the red fluorescent dyes results in an orange-yellow signal. Photographs were taken with an Imagerecorder (Focus Graphics Inc., San Francisco, CA, USA).
The region between the cut ends of the fornix is called the lesion site or lesion centre, while the area surrounding the lesion site is called the perilesional area.
In all figures, the proximal stump of the fornix tract is on the left side of the micrographs, and the distal fornix is on the right.
Electron microscopy
For ultrastructural analysis vibratome sections of anti-Coll IV treated and anterogradely traced animals (see Table 1 ) were reacted for WGA-HRP as described above, immersed for 12 h in 1% osmium tetroxide, dehydrated in an ascending series of ethanols and propylene oxide and flat embedded in epon. Representative ultrathin sections of the lesion site were contrasted with lead and uranyl salts and examined using a Hitachi H600 electron microscope.
Electrophysiology and biocytin tracing
Sagittal slices of 400 µm thickness were cut on a vibratome and maintained at 34-35°C in an interface-type recording chamber. Artificial cerebrospinal fluid (ACSF) consisted of (in mM): NaCl, 124; KCl, 3; NaH 2 PO 4 , 1.25; MgSO 4 , 1.8; CaCl 2 , 1.6; NaHCO 3 , 26; and glucose, 10, with a pH of 7.4 when saturated with 95% O 2 -5% CO 2 . Electrical stimuli of 100 µs duration and 5-20 V in amplitude were delivered via a bipolar tungsten electrode (FHC, Brunswick, ME, USA; 4-5 MΩ).
Extracellular action potentials were recorded with a glass microelectrode (3-5 MΩ) located in the middle of the postcommissural fornix. Stimulus intensity was gradually increased until a maximal response could be observed at the recording site. The response was analysed in its amplitude and the conduction velocity was determined by dividing the distance between recording and stimulating site by the temporal delay between stimulus artefact and response onset. Tetrodotoxin (TTX, Sigma) was applied locally in a concentration of 10 µM (dissolved in ACSF) with a broken micropipette placed on the slice surface near the recording site.
In all slices the postcommissural fornix tracts were anterogradely traced with biocytin. Under microscopic control small crystals of biocytin (Sigma, Basel, Switzerland) were placed with a small enthomological needle into the proximal fornix tract. After an incubation period of 8-10 h in the interface chamber, slices were fixed for 24 h with 4% paraformaldehyde in 0.1 M PB, followed by washes in PB and cryoprotection with 30% sucrose overnight. Slices were resectioned on a freezing vibratome, washed in PB and processed overnight with ABC-kit (Vector Standard kit, Vector Laboratories). The diaminobenzidine reaction product was intensified with OsO 4 .
Results
Deposition of BM and axonal growth arrest in the transected postcommissural fornix
In the acute postoperative period a prominent zone of necrosis surrounded the transection site. This area was filled with macrophages but was free of Coll IV, LN and NF immunoreactivities B) . While at 4 days after lesion the degenerative changes persisted, the first signs of BM formation became evident. Single fine segments of BM were randomly distributed at the lesion site. By the end of the first week an almost continuous BM appeared at the transection site (Fig. 2D,E) . This newly formed BM penetrated the full depth of the lesion and was either associated with numerous blood vessels or arranged in elongated layers. During the following days the number of deposited BM sheets increased and at 14 days, an extensive and continuous BM had appeared (Figs 2G, H and 3A) . The mature BM exhibited strong Coll IV and LN (not shown) immunoreactivities and formed a parallel array aligned perpendicular to the course of the tract ( Figs 2H and 5 ). In the vicinity of the transected stumps, however, BM layers were deposited as hook-like turns extending along the longitudinal tract axis for about 200 µm into the fornix stumps. Throughout the remainder of the experimental period (up to 9 weeks), this organization of the BM was maintained.
In parallel with the deposition of the BM, NF-immunopositive sprouting axons in the proximal stump reached the lesion site (Figs 3 and 4) . Confocal microscopy of sections double-labelled with anti-Coll IV and anti-NF revealed a wide range of axon-BM relationships. While single axons were intimately associated with Coll IV immunoreactive BM in the lesion centre, others were arrested at BM deposits or even made hook-like turns (Fig. 3B,D) . However, anterograde tracing with WGA-HRP and serial reconstruction provided evidence that no single fibre succeeded in crossing or bypassing the BM (Fig. 4) . After an initial retrograde degeneration within the first 5 days after lesion, transected axons spontaneously sprouted through the perilesion area (Stichel et al., 1995b) but stopped abruptly at the wound border in spatiotemporal coincidence with the BM maturation, at about 2 weeks after lesion (Fig. 3) . The growth arrested fibres persisted at this position for at least 6 weeks after injury.
Reduction of BM deposition by local injection of anti-Coll IV antibodies or dipyridyl
In an effort to modulate postlesion BM deposition, either polyclonal antibodies directed to Coll IV (anti-Coll IV) or the iron chelator DPY were injected locally into the transection site immediately after lesion. DPY is a competitive inhibitor of prolyl-4-hydroxylase and has been shown to prevent collagen triple helix formation (Kivirikko et al., 1989) , which results in a feedback inhibition of procollagen synthesis (Ikeda et al., 1992) and enhanced procollagen degradation (Bienkowski, 1984) .
Animals receiving an injection of anti-Coll IV or DPY showed a massive and specific reduction of Coll-and LN-immunopositive laminae and blood vessels in the lesion centre and the fornix stumps at all examined survival time points. At 2 weeks after lesion ϩ injection, the time point of axonal growth arrest, only a very small number of Coll-immunoreactive structures perpendicular to the tract course had developed (Fig. 5) . Animals with PBS, antihuman IgG or sham injection, however, exhibited dense BM deposition as previously described for lesion-only animals (Fig. 5) . While after anti-Coll IV or DPY injection the deposition of BM was markedly reduced at the lesion site, the applied substances did neither affect the number nor the distribution of vascular BM in the surrounding neuropil (Figs 5 and 7) . Despite the significant reduction in BM no cavity formation was observed at the lesion site.
Axonal regeneration in lesioned animals with reduced BM deposition
To determine whether reduction of BM deposition would permit regrowing fornix fibres to cross the lesion site, we studied the elongation of transected axons after anti-Coll IV or DPY treatment.
Up to 4 days after surgery the overall appearance of the transected fornix in animals with anti-Coll IV or DPY injection was similar to that in control animals (Fig. 6A,B) . In no case did the injected substances influence the lesion-induced degeneration. However, already 2 days later (6 days after surgery) there was a significant difference in fibre advance between treated and control animals. In anti-Coll IV or DPY treated animals some sprouting axons either extended into or even traversed the lesion centre and entered the distal stump (Fig. 6C,G) . In contrast, in all control animals with transection plus PBS or antihuman IgG injection sprouting axons ceased growing at the proximal stump-lesion interface (Fig. 4) . Animals with the standard lesion and DPY injection, that received a second more proximal fornix transection without DPY failed to regenerate despite BM reduction at the more distal lesion site. The latter indicates that DPY does not prevent degeneration of transected axons and confirms the completeness of our lesion procedure.
The number of fibres that succeeded in crossing the modified lesion site increased during the following weeks. At 6 weeks after surgery large numbers of fibres crossed the transection site (Figs 4, 7, 8 and 9A) . This numerical increase in crossing axons between 6 days and 6 weeks postsurgery indicates that not all regenerating axons within one animal cross the modified lesion scar at the same time. Accordingly, growth cone-like structures were easily identified up to 14 days postsurgery (Fig. 6E,F,I ,K), but at later stages the identification was hampered by the high axon density.
In total 14 of 17 rats that received anti-Coll IV or DPY treatment and were analysed 6-9.5 weeks postinjection exhibited axonal regeneration across the lesion site. In all animals with regeneration a small proportion of the axons that spontaneously sprouted up to the lesion site did not succeed in crossing the modified scar.
On their way through the lesion site the regrowing axons exhibited a remarkable tendency to regenerate in the correct direction following their previous course. They followed the upwards displaced proximal stump and then recurved back into the distal stump, forming the typical ∧-like loop. (Figs 6C,G, 7 and 8). At early time points axons crossed the scar as a perturbed array rather than as an orderly parallel fibre bundle (Fig. 6D,H) . Later with increasing axon number they formed parallel bundles of fine and beaded axons within their former pathway, the postcommissural fornix (Figs 7 and 8) . The regenerating axons elongated through their former pathway and reached their appropriate target, the mammillary body (Figs 4, 8 and 9 ). Although unspecific recruitment of nearby axons could account for some of the regenerating axons the anterograde tracing with WGA-HRP injected into the subiculum, the origin of the fornix (Fig. 4) and the biocytin application into the proximal fornix stump (Fig. 9A) provided proof, that the vast majority if not all of the regenerating fibres in the distal fornix pathway emerged from the proximal stump. Moreover, the similarity in axon numbers of anterogradely labelled and immunohistochemically stained tracts and the lack of fibres that cross the tract boundary strongly support the latter conclusion. All regenerating fornix axons remained within their 
Histological and electrophysiological recovery of regenerating axons
Prerequisites for recovery of functional circuitry after traumatic CNS lesion are: (i) the remyelination of regenerated fibres; (ii) the reestablishment of synaptic connections with the appropriate target; and (iii) the restoration of normal conduction properties. This prompted
FIG. 4. Serial sections of anterogradely traced fornix tracts at 6 weeks after transection ϩ PBS injection (A-C) or transection ϩ DPY injection (AЈ-CЈ). (A-C)
Anterograde tracing and reconstruction of the transected fibre tract in 50 µm thick vibratome sections reveals that the sprouting axons stop abruptly at the centre of the transection site (arrows) and no single axon succeeds in crossing or bypassing this area. The distal stump (d) is free of traced axons. (AЈ-CЈ) Anterograde tracing and reconstruction of a transected and DPY treated fibre tract in 50 µm thick vibratome sections. Axons succeed in crossing the transection site (arrows) and elongate within their former pathway the distal stump (d) up to their normal target, the mammillary body (MB). p, proximal. Scale bars, 100 µm.
us to investigate the structural and functional properties of the regenerating axons.
Immunohistochemistry with an antibody against MBP demonstrated remyelination of the regenerated fornix axons along their entire length (about 1 mm) as early as 3 weeks after surgery (data not shown). This observation was confirmed by ultrastructural analysis of anterogradely WGA-HRP-labelled axons in the distal fornix stump, which showed clear evidence of compact myelin sheath formation (Fig. 9C ). In addition, ultrastructural studies provided evidence for the re-establishment of synaptic connections of regenerating axons within the mammillary body. Tracer reaction product was identified in presynaptic profiles containing round vesicles that formed asymmetric synaptic junctions at unlabelled dendrites (Fig. 9D,E) .
The electrophysiological properties of regenerated fornix fibres were studied using extracellular in vitro recording techniques applied to sagittal brain slices (400 µm) of four treated animals and compared with recordings of eight unlesioned rats (Fig. 10) . In unlesioned animals electrical stimulation of the fornix fibres elicited extracellular action potentials with an amplitude of 1.02 Ϯ 0.14 mV and a conduction velocity of 0.48 Ϯ 0.05 m/s (mean Ϯ SEM, n ϭ 16). Similar values for action potential amplitude and conduction velocity (1.12 Ϯ 0.21 mV, 0.46 Ϯ 0.1 m/s, n ϭ 5) were obtained in regenerating animals when the stimulating (S) and the recording (R) electrodes were positioned proximally to the lesion site (see S1 and R1 in Fig. 10A ). In the latter animals, functionally intact fibres showing normal extracellular action potential amplitude and conduction velocity could also be demonstrated across (S3 and R3 in Fig. 10A ; 0.8 Ϯ 0.29 mV, 0.54 Ϯ 0.14 m/s, n ϭ 3) and distal to the lesion site (S2 and R2 in Fig. 10A ; 0.91 Ϯ 0.24 mV, 0.43 Ϯ 0.06 m/s, n ϭ 4) (Fig. 10C,D) . Both in controls and in slices showing regeneration the stimulus-evoked extracellular responses could be blocked by TTX, confirming their nature as Na ϩ -dependent action potentials (Fig. 10B) . In animals with transection only, no signals could be recorded across and distal to the lesion site.
Discussion
The experiments reported in this study were designed to assess the role of BM in regeneration failure of a CNS fibre tract in adult mammals. In the mechanical transected postcommissural fornix we show that: (i) there is a spatiotemporal coincidence of BM deposition and growth arrest of spontaneously sprouting axons; (ii) postlesion injection of anti-Coll IV antibodies or the iron chelator DPY significantly reduce the lesion-induced BM formation; (iii) reduction of BM formation is a prerequisite and sufficient condition for the regrowing axons to cross the lesion site; and (iv) fornix axons have an innate potential for regeneration and target innervation. The results of this study provide strong evidence that lesion-induced BM is an environmental restriction for axonal regeneration in adult mammalian CNS.
Role of BM in regeneration failure
The formation of a lesion scar with reactive astrocytes, changes in extracellular matrix composition and the deposition of a BM as crucial elements is one of the cardinal features of the histopathology of lesioned mature CNS. However, the relationship of the lesion scar and regeneration failure has a long-lasting history of controversial discussion. On the one hand, it has been suggested that the formation of a lesion scar is clearly beneficial, in that it re-establishes the integrity of the CNS (Maxwell et al., 1990 ) and may even assist or sustain the growth and survival of axonal sprouts . On the other hand, several experiments provided a body of evidence that the lesion scar limits successful regeneration (Ramón y Cajal, 1928; Windle et al., 1951; Clemente, 1955; Puchala & Windle, 1977; Reier et al., 1983; Schnell & Schwab, 1993; Anders FIG. 7 . Crossing of lesion scar after treatment with DPY at 6 weeks after treatment with DPY. Section double-labelled for Coll IV (red) and NF (green), visualized by confocal microscopy, shows regrowing axons that cross a lesion site (A) with reduced BM formation (B). of axonal growth arrest and scar formation, and (ii) the sustained growth of transected fibres across the lesion site after biochemical or immunochemical modulation of the lesion scar.
Over the last years considerable attention has been devoted to © 1999 European Neuroscience Association, European Journal of Neuroscience, 11, [632] [633] [634] [635] [636] [637] [638] [639] [640] [641] [642] [643] [644] [645] [646] elucidate the factors of the lesion scar responsible for the inhibition of axonal outgrowth. Traditionally, regeneration failure at the lesion scar was related to the prominent astrogliosis in this area; that might act as a mechanical constraint to regrowing axons  Wells . In a previous set of experiments we showed that regrowing fornix axons are able to penetrate a dense astrocytic scar (Stichel & Müller, 1994) . Another current hypothesis favours the local lesion-induced expression of molecules that might inhibit axon advance. Such molecules which might be responsible for regeneration failure include tenascin C and various proteoglycans (Giftochristos & David, 1988; Faissner & Kruse, 1990; McKeon et al., 1991; Dow et al., 1993; Dow et al., 1994; McKeon et al., 1995; FIG. 10 Davies et al., 1997) . Strong evidence for an involvement of the latter in growth arrest comes from a recent study of Davies and co-workers (Davies et al., 1996) . They showed in a microlesion model that cut axons fail to regenerate in the presence of a continuous aligned astroglial pathway and growth arrest at a proteoglycan-rich boundary. However, our previous studies demonstrate that regrowing fornix axons penetrate tenascin C or chondroitin sulphate proteoglycan-rich areas (Lips et al., 1995; Stichel et al., 1995a) . Other types of inhibitory molecules, which might be responsible for scar-mediated growth arrest are the myelin and oligodendrocyteassociated neurite growth inhibitors NI 35/250 and the myelin-associated glycoprotein MAG (McKerracher et al., 1994; Mukhopadhyay et al., 1994) . However, in an earlier study we have shown that the abortive phase of axon growth is arrested in a region of the lesion area that is free of myelin and oligodendrocytes (Stichel et al., 1995b) .
Besides the astrogliosis or myelin-associated growth inhibitors a third potential candidate for axonal growth arrest at the lesion scar is the BM, which is deposited in the centre of the wound. The results of the present studies provide strong evidence for a central role of BM in regeneration failure. Regrowing postcommissural fornix axons arrest abruptly in close proximity to the BM deposits in the lesion centre, but continue to elongate when the BM is reduced. Our findings are in line with (i) in-vitro studies showing contact inhibition of axonal elongation by adult scar explants with large amounts of BM deposited around reactive astrocytes (Rudge & Silver, 1990) and (ii) in-vivo studies in spinal cord showing that regrowing axons do not cross but rather turn back at lesion-induced (Kao et al., 1977; Feringa et al., 1980) or implanted BM (Hausmann et al., 1996) and at pure collagen implants (Gelderd, 1990; Marchand & Woerly, 1990; Joosten et al., 1995) , respectively.
Several important biological functions are ascribed to BM (for review see Timpl & Dziadek, 1986) . BM supports proper maintenance and compartmentalization of tissue architecture, induces cell differentiation and migration and provides a substratum for cell attachment, spreading and process outgrowth. The latter feature seems to be contradictory to the predicted growth-arresting function in CNS lesions. However, there are two possible explanations for this apparent discrepancy: First, BM orientation relative to the axon course could be important. While in the in-vitro approaches the BM is orientated in parallel to the fibre course, the orientation of the BM in the lesion scar is perpendicular to the regrowing axons. And second, there might be differences in the molecular composition of the BM in vivo vs. in vitro.
However, the present approach does not allow characterization of the molecular or cellular nature of the growth inhibitor associated with the BM. The latter might contain up to 50 different components anchored in a basic collagen/LN network (Timpl & Dziadek, 1986) , including also potential growth-inhibitory molecules like proteoglycans. Moreover, the BM is closely associated with various glial cells, which might also exert growth-inhibitory effects. All of these components may be indirectly affected by the accomplished treatment. Preliminary studies in our laboratory, however, demonstrate that the reduction of BM deposition does neither influence the formation of the reactive astroglial network nor the accumulation of microglia/ macrophages in the lesion site (Stichel, C.C., Niermann, H., D'Urso, D., Lausberg, F., Hermanns, S. & Müller, H.W., unpublished results). Finally, the BM could still comprise a physical growth barrier. Therefore, additional interventions are needed in order to explain the growth inhibitory nature of the BM deposited in CNS lesion sites.
Reduction of BM formation-an experimental approach to foster regeneration
Beginning with the study of Windle et al. (1951) many procedures have been used to modulate the lesion interface, including surgical and pharmacological strategies. A classical approach was the application of enzymes, such as trypsin and collagenase (for review see Puchala & Windle, 1977) to permeabilize the scar. First reports of these studies indicate that the treatment may have diminished the density of the collagenous scar, while more recent reports show that none of these procedures improved axonal regeneration or permitted functional restitution (reviewed in (Guth et al., 1980) . One major drawback of the enzyme approach is the simultaneous digestion of vascular BM, which results in alteration of extracellular milieu or haemorrhages and might therefore impair axonal regeneration.
More recent attempts to reduce BM formation are the application of glucocorticoids (Li & David, 1996) or the infusion of an antibody against transforming growth factor β1 (Logan et al., 1994) after cortical stab wound lesion. While these strategies significantly modified the density and integrity of the BM, no effects on axonal regeneration have been reported yet. Thus, our experimental strategy to reduce the BM formation by interfering with the biosynthesis or fibrillogenesis of Coll IV is the first approach inducing repair of a lesioned fibre tract and provides the first direct support for the hypothesis that BM is an impediment to axonal regeneration.
Our data seem to contradict the current opinion that successful regeneration will require a combination of appropriate neurotrophic support and neutralization of growth-inhibitory molecules or structures (Logan & Berry, 1993; Schnell et al., 1994; Jackowski, 1995) . However, in our lesion model the axons are transected near to their normal target and it remains to be seen in future investigations whether or not reduction of BM formation will also be sufficient to induce regeneration of axons that are lesioned more distant to their normal target.
Recovery of structural and functional characteristics
In this study we show that reduction of BM deposition is a prerequisite but also a sufficient condition for the transected postcommissural fornix axons to regenerate. Regrowing axons that succeeded in crossing the lesion site re-entered their former pathway and elongated up to their normal target. The fibres became remyelinated and re-established normal conduction properties. Analysis of postsynaptic responses in reinnervated neurons of the mammillary body was hampered by the non-laminated architecture of the mammillary body and the diffuse spreading of afferent fibres. The latter do not allow the recording of field potentials with significant amplitude.
An amazing observation of the present study is the great precision with which the regenerating fibres followed their previous pathway. This behaviour is even more surprising regarding the lesion-induced separation of proximal and distal stumps. The precision is similar to that previously described in our Schwann cell paradigma (Stichel et al., 1996) and could reflect either an inherent capacity of the fornix fibres to find their appropriate target or the presence of guidance cues and/or target-derived tropic factors. Data described here also demonstrate that once the fornix axons have crossed the lesion scar other potential extrinsic regeneration constraints, such as CNS myelin and oligodendrocytes McKerracher et al., 1994; Mukhopadhyay et al., 1994; Stichel et al., 1995b) , dense astrogliosis (Stichel & Müller, 1994) or sulphated proteoglycans (Snow et al., 1990; Lips et al., 1995) do not impede their progress. Other interesting findings of the present study are the spontaneous remyelination of the axons and their capacity to re-establish electrophysiological properties and synaptic contacts. While further studies are required to demonstrate whether or not the synaptic connections are topographically correct and functional, the present findings suggest that lesioned neurons retain or regain intrinsic programmes for cell-cell contact and structural plasticity.
In conclusion these studies provide unequivocal evidence that lesion-induced synthesis and deposition of BM impairs regeneration of regrowing CNS axons. Reduction of BM formation leads to dramatic structural and functional recovery.
